Meet Eva Hellström-Lindberg, our Volunteer of the Month

Voulenteer of the month template website Eva Hellstroem Lindberg

I was nominated to be on the EHA Ballot in 2000 and to my surprise and happiness, I was elected as Councilor. I became President-elect in 2003 and was the EHA President 2005-2007.

Read more

ATMPs and CAR-T: the uptake challenge

HemAffairs ATMPs and CAR T

Advanced therapy medicinal products (ATMPs) are a game changer for improving the lives of patients with severe to life-threatening diseases. Yet, despite fast-paced innovation in the field, few ATMPs have reached the EU market and benefited patients. The challenges facing their adoption by health systems are complex. A test case is the uptake of CAR T-cell therapy; what are the hurdles and what action is needed from stakeholders?

Read more

EU health policy: limited scope, high ambition

HemAffairs EU health policy

While health policy remains the primary responsibility of Member States, in many areas the added value of EU-level collaboration and harmonization has increased. EU initiatives in health have shown a mixed record in terms of impact, but hopes are high for the latest one, the ambitious Europe’s Beating Cancer Plan.

Read more

Meet Helen Papadaki, our January volunteer of the month

Helen Papadaki website

Can you tell us what you do for EHA and when you started? I am currently a Councilor of the EHA Board for the period 2016-2020, chair of the EHA Membership…

Read more

EHA-SWG Scientific Meeting on Systemic Risk of Thrombosis or Bleeding

IMG 2537

EHA-SWG Scientific Meeting on Systemic Risk of Thrombosis or Bleeding

November 22-24, 2019 |Madrid, Spain

Read more

A well-attended second meeting from the European Hematology Association (EHA) an…

WhatsApp Image 2019 12 18 at 16.38.59 7

For the second time the European Hematology Association (EHA) and the EHA Scientific Working Group on Red Cell and Iron joined in the organization of the meeting focused on Red…

Read more

Meet Michaela Gruber, our December volunteer of the month

Michaela Gruber website
Dr Michaela Gruber was one of the initiators of YoungEHA as well as a founding member of the YoungEHA Committee. Meet Michaela Gruber and learn about what she does and why she has been volunteering for EHA for all these years.
Read more

Revising the ICH Guidelines on Clinical Trials

Delegation HemAffairs

Clinical trials and drug development have become more complex over the years. One complicating factor is the increased administrative burden, as was pointed out in the previous edition of HemAffairs. Doctors and clinical researchers are more and more bound to rules they deem neither necessary nor effective. At first sight, the requirements for clinical trials seem clear and thorough. Nonetheless, the interpretation and implementation of these rules leave room for improvement.

Read more

The past and future of the EU Blood, Tissues and Cells legislation

Annake HemAffairs HR

Blood, tissues and cells (BTC) are used in medicine and in hematology on a daily basis. EU legislation has been in place for over 15 years to regulate those practices, and to ensure safety and quality standards for substances of human origin (SoHO). For instance, through technical and traceability requirements for BTC, the reporting of serious adverse reactions (SARs), and verification procedures for imported BTC.

Read more

EHA at ICH meeting: Excessive bureaucracy harms patient safety and innovation

EHA delegation to ICH public meeting

To solicit input from a wide range of non-ICH members about the revision of ICH E8(R1), ICH held a Public Meeting on ICH E8(R1) “General Considerations for Clinical Studies” (Silver Spring, USA, October 31, 2019).

Read more

EHA-SWG Scientific Meeting on Granulocytes and Constitutional Marrow Failure Syn…

WhatsApp Image 2019 11 14 at 18.04.29

The second scientific meeting on EHA-SWG Scientific Meeting on Granulocytes and Constitutional Marrow Failure Disorders and Leukemia Predisposing Genes was held on October 10-12, 2019 in Prague, Czech Republic.

Read more

1st joint EHA – Balkan Hematology Day, a meeting of true regional commitment

WhatsApp Image 2019 11 14 at 17.58.53

On Friday, October 11th the European Hematology Association (EHA) co-organized with the national societies from the Balkan countries for the first joint Balkan Hematology Day. The meeting focused on lymphoid malignancies and CAR-T and the topics acute myeloid leukemia, acute lymphoblastic leukemia and CAR-T cells presented by international faculty and local clinical case presenters, resulted in a strong program with valuable messages.

Read more

EHA-AHA Hematology Tutorial On Lymphoid Malignancies Attracts International Audi…

Armenia Tutorial report image 1

The 3rd joint Hematology Tutorial with the Armenian Hematology Association was held in October 2019, focusing this time on Lymphoid Malignancies. The meeting covered both biological and clinical aspects, giving participants the knowledge to better identify symptoms, make proper classifications and follow appropriate treatment options for each stage and age group.

Read more

Meeting report | HOPE LA 2019 | Mendoza, Argentina

HOPE LA meeting report image 1 a

The first edition of the Highlights of Past EHA (HOPE) meeting in Latin America (LA) was held on October 4-5, 2019 in Mendoza, Argentina. The meeting concluded the biennial congress of the Sociedad Argentina de Hematología (SAH), HOPE LA’s main partner this year.

Read more

Meet Stefan Fröhling, our November volunteer of the month

Voulenteer of the month 2
Professor Stefan Fröhling was first introduced to EHA in 2002 when he attended the 7th EHA Congress in Florence. He has served in a number of committees and has been an EHA Board Member (2013-2017). Currently, Professor Fröhling is a member of the EHA Scientific Working Group Unit and an Associate Editor of HemaSphere, the official journal of EHA.
Meet Stefan Fröhling and learn about what he does and why he has been volunteering for EHA for all these years.
Read more